BioMarin Pharmaceutical, Inc. (BMRN)

$16.35 -0.10 (-0.64%)

11/30/2009 11:43 AM

CAPS Rating

Open

$16.84

Previous Close

$16.46

Daily Range

$16.13 - $16.84

52-Week Range

$9.93 - $21.23

Market Cap

$1.65B

P/E Ratio

36.89

Dividend (Yield)

N/A (N/A)

Volume

539,460

Average Daily Volume

1,308,000

BMRN VS S&P 500 (SPY)

Caps

Motley Fool CAPS is a community working together to find better stocks and to become better investors.

UPDATE 1-BioMarin autoimmune disease drug gets orphan status2 hours ago – Reuters
The Next Million-Dollar Penny StockNovember 27, 2009 – The Motley Fool
CNBC on BioMarin Pharmaceuticals IncNovember 13, 2009 – Ockham-RazorWire
Finally Convinced? Benlysta Works!November 02, 2009 – The Motley Fool
Earnings? Yawn. Trial Data? Moving!October 30, 2009 – The Motley Fool
This Week's 5 Smartest Stock MovesOctober 30, 2009 – The Motley Fool
Small and Volatile, but Not for LongOctober 29, 2009 – The Motley Fool
Small Market, Small Acquisition, Still a Good MoveOctober 27, 2009 – The Motley Fool
Build Your Fortune With These WinnersOctober 21, 2009 – The Motley Fool
The Next Million-Dollar Penny StockOctober 09, 2009 – The Motley Fool
Biomarin (BMRN) possible buyoutSeptember 10, 2009 – Blog at The Motley Fool
Is There Life After a 714% Return?August 28, 2009 – The Motley Fool
7 Stocks With a Bright FutureAugust 28, 2009 – The Motley Fool
The Cash Cow Is Out of MilkAugust 05, 2009 – The Motley Fool
The Little Orphan That CouldJuly 31, 2009 – The Motley Fool
Overnight Triple! Yee-Haw!July 20, 2009 – The Motley Fool
A Meaningless FDA Approval ... for NowJune 19, 2009 – The Motley Fool
Going Viral, but Not in a Good WayJune 16, 2009 – The Motley Fool
Where Good Drugs Go to DieJune 12, 2009 – The Motley Fool
4-Star Stocks Poised to Pop: BioMarinMay 27, 2009 – The Motley Fool